US$ 23.72
f45 glp 1 Training Expands Wellness Focus with GLP-1 Medications F45 Training Partners With REP
Description
Exec SummaryDanuglipron is an experimental weight loss medication being developed by Pfizer

Read Important Safety and Prescribing Information, including Boxed Warning.

GLP-1s are a class of medications originally approved for type 2 diabetes management that have seen dramatic growth in prescribing following expanded approvals for chronic weight management

It also provides key minerals that help regulate appetite and support metabolic balance
